U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. CPG Sec. 440.100 Marketed New Drugs Without Approved NDAs and ANDAs
  1. Regulatory Information

COMPLIANCE POLICY GUIDE (CPG)

CPG Sec. 440.100 Marketed New Drugs Without Approved NDAs and ANDAs September 2011

Final

CPG Sec. 440.100 Marketed New Drugs Without Approved NDAs and ANDAs


Submit Comments

Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)

If unable to submit comments online, please mail written comments to:

Division of Dockets Management (HFA- 305)
Food and Drug Administration
5630 Fishers Lane, Rm. 1061
Rockville, MD 20852

All comments should be identified with the title of the guidance.